Biotechnology company INOVIO has been awarded $71m funding from the US Department of Defense (DoD) for its Covid-19 vaccine delivery device. The grant will support the large-scale production of INOVIO's proprietary intradermal DNA delivery smart device CELLECTRA 3PSP and the procurement of CELLECTRA 2000 devices. These devices are designed to deliver the company’s INO-4800 vaccine directly into the skin. INO-4800 vaccine is being developed to protect against the novel coronavirus SARS-CoV-2, which causes COVID-19.

The post Coronavirus company news summary – ADF asked to manage quarantine sites – Indian Armed Forces exempt personnel from quarantines appeared first on Army Technology.